Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rama D Jager, MD
Eyecheck, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Luna Research
Coral Gables, Florida, United States
Carlos BelloRecruiting - Prohealth Research Center
Doral, Florida, United States
David JativaNot, yet, recruiting - Solution Clinical Research
Doral, Florida, United States
Santos ReyesRecruiting - South Florida Research
Medley, Florida, United States
Giralt YanezRecruiting - A&a Research Group
Miami, Florida, United States
Nelson SanchezRecruiting - Davila Medical Research
Miami, Florida, United States
DieguezRecruiting - Dynamic Medical Research
Miami, Florida, United States
Reinaldo Hernandez-LoyRecruiting - G+c Research Group
Miami, Florida, United States
Alina AlvarezRecruiting - the Miami Research Group
Miami, Florida, United States
Manuel FrancoNot, yet, recruiting - Vista Health
Miami, Florida, United States
Antonio Blanco, ERecruiting - Affinity Clinical Research
Tampa, Florida, United States
Cecilio HernandezRecruiting - Beat Covid
Oak Forest, Illinois, United States
Rama D Jager, MDRecruiting - Dorisca Research Consulting
Houston, Texas, United States
Anand BalasubramanianRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Nov 2021
- Primary completion
- 31 Dec 2022
- Completion
- 31 Aug 2023
- Last update posted
- 9 Sept 2022
- Registered enrollment
- 598
- Registry id
- NCT05046561
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.